Here's Why You Should Retain Nutrien Stock in Your Portfolio

Nutrien (NTR) is supported by record potash sales volume in 1H 2024 from healthy global fertilizer demand and low North America channel inventories, plus higher phosphate volumes and stable nitrogen volumes. However, softer phosphate and potash prices since mid-2022 are expected to pressure near-term sales and profitability, even as cost/operational efficiency and lower natural gas and input costs reduce cost of goods sold. The company is also pursuing further targeted acquisitions (building out Brazil) and expects these actions to help defend free cash flow amid the fertilizer price headwind.

Analysis

NTR is still a volume story first and a pricing story second. In a fertilizer downcycle, stable tons can look reassuring while EBIT actually compresses because the marginal producer keeps resetting benchmark prices; lower gas and ammonia costs help, but they mainly protect the floor, not restore peak margins. That means the stock can look “fundamentally okay” while multiple expansion remains capped until pricing inflects.

The second-order read-through is that cost cuts and targeted M&A may improve reported free cash flow without improving true cycle power. If NTR is buying Brazil exposure into softer realized pricing, incremental growth could be less accretive than it appears, especially if competitors use cheap energy to keep operating rates high. That dynamic also argues against chasing the broader fertilizer complex here: the best near-term relative trades are likely the lowest-cost or best-revision names, not the most diversified one.

The contrarian view is that the market may already be discounting a lot of the bad news after a multi-quarter drawdown, so downside from here is less about demand collapsing and more about estimates drifting lower. The key falsifier over the next 1-3 months is any evidence that potash/phosphate pricing stabilizes into seasonal buying and that management holds FCF guidance despite weak realized prices. If those two don't happen, this remains a dead-money-to-lower setup rather than an attractive mean reversion.

Key Decisions for Investors

• Hold NTR only as a core-minus position for now; do not add until next pricing data shows stabilization. Time horizon: 1-3 months. Risk/reward: limited upside unless fertilizer ASPs stop falling; downside resumes quickly if guidance is cut.
• Use strength to initiate a short-dated NTR put spread into the next earnings/guidance window. Time horizon: 4-8 weeks. Thesis works if realized potash/phosphate pricing slips again; invalidated if management reiterates FCF and margins.
• For materials exposure, prefer a relative long NEM or EGO versus NTR over 3-6 months. The gold names have cleaner earnings revision momentum, while NTR remains hostage to fertilizer pricing. Falsifier: if fertilizer prices stabilize and NTR re-rates on FCF, the pair loses edge.
• Watch MOS and CF as higher-beta fertilizer proxies; if they underperform NTR on the next leg down, that confirms the market is pricing in a broader nutrient price reset rather than a company-specific issue.
• Set an alert for any upward revision to NTR full-year margin/FCF guidance or for a two-month stabilization in benchmark potash/phosphate prices; either would justify covering bearish exposure.